Background: Gastrointestinal bleeding (GIB) is one of the most common medical emergencies. We investigated the overall mortality after GIB in our institute and analyzed the prognostic factors in upper GIB (UGIB) and lower GIB (LGIB) separately. Summary: Between January 2010 and December 2018, 190 patients diagnosed with GIB in our hospital were retrospectively enrolled. Clinical records and biological data were collected. Risks for rebleeding and in-hospital mortality were assessed by a logistic regression analysis. Overall, the rebleeding rate and in-hospital mortality were 22.6 and 7.6%, respectively. GIB itself was not the direct cause of death in any cases. While older age (>65 years) was a significant risk factor for rebleeding in UGIB with an OR of 6.1 and 95% CI of 1.3–29.1, a poorer performance status (PS; ≥3) was a strong risk factor for rebleeding in LGIB, with an OR of 11.8 and 95% CI of 1.7–83.8. Poor PS and tachycardia (>100/min) were significantly associated with mortality in both UGIB and LGIB. In contrast, hypoalbuminemia (<3.0 g/dL) was associated with the mortality in LGIB alone. Key Messages: There were considerable differences in the risk factors for rebleeding and in-hospital mortality between UGIB and LGIB. The overall in-hospital mortality was 7.9% after GIB, including that a substantial portion of patients with GIB died from systemic complications after successful endoscopic hemostasis. Physicians need to diligently perform systematic treatment for GIB, which may be particularly important in societies of advancing aging, like Japan.

Journal Section:
Research Article
Keywords:
Gastrointestinal bleeding, Upper gastrointestinal bleeding, Lower gastrointestinal bleeding
1.
Asaki S, Nishimura T, Sato A, Yamagata R, Okubo S, Toyohara T, et al. Multiinstitutional evaluation of local injection of absolute ethanol as the new hemostatic method for upper G-I tract bleeding. Tohoku J Exp Med. 1985 Feb;145(2):137–47.
2.
Goto H, Ohta S, Yamaguchi Y, Yukioka T, Matsuda H, Shimazaki S. Prospective evaluation of hemoclip application with injection of epinephrine in hypertonic saline solution for hemostasis in unstable patients with shock caused by upper GI bleeding. Gastrointest Endosc. 2002 Jul;56(1):78–82.
3.
Kanai M, Hamada A, Endo Y, Takeda Y, Yamakawa M, Nishikawa H, et al. Efficacy of argon plasma coagulation in nonvariceal upper gastrointestinal bleeding. Endoscopy. 2004 Dec;36(12):1085–8.
4.
Aoki T, Nagata N, Shimbo T, Niikura R, Sakurai T, Moriyasu S, et al. Development and Validation of a Risk Scoring System for Severe Acute Lower Gastrointestinal Bleeding. Clin Gastroenterol Hepatol. 2016 Nov;14(11):1562–1570.e2.
5.
Nahon S, Pariente A, Nalet B, Hagège H, Latrive JP; group of investigators of the ANGH (Association Nationale des Gastroentérologues des Hôpitaux Généraux). Causes of mortality related to peptic ulcer bleeding in a prospective cohort of 965 French patients: a plea for primary prevention. Am J Gastroenterol. 2010 Aug;105(8):1902–3.
6.
Nakamura S, Matsumoto T, Sugimori H, Esaki M, Kitazono T, Hashizume M. Emergency endoscopy for acute gastrointestinal bleeding: prognostic value of endoscopic hemostasis and the AIMS65 score in Japanese patients. Dig Endosc. 2014 May;26(3):369–76.
7.
Sung JJ, Tsoi KK, Ma TK, Yung MY, Lau JY, Chiu PW. Causes of mortality in patients with peptic ulcer bleeding: a prospective cohort study of 10,428 cases. Am J Gastroenterol. 2010 Jan;105(1):84–9.
8.
Rockall TA, Logan RF, Devlin HB, Northfield TC. Risk assessment after acute upper gastrointestinal haemorrhage. Gut. 1996 Mar;38(3):316–21.
9.
Blatchford O, Murray WR, Blatchford M. A risk score to predict need for treatment for upper-gastrointestinal haemorrhage. Lancet. 2000 Oct;356(9238):1318–21.
10.
Abougergi MS, Travis AC, Saltzman JR. The in-hospital mortality rate for upper GI hemorrhage has decreased over 2 decades in the United States: a nationwide analysis. Gastrointest Endosc. 2015 Apr;81(4):882–8.e1.
11.
Abougergi MS, Charpentier JP, Bethea E, Rupawala A, Kheder J, Nompleggi D, et al. A Prospective, Multicenter Study of the AIMS65 Score Compared With the Glasgow-Blatchford Score in Predicting Upper Gastrointestinal Hemorrhage Outcomes. J Clin Gastroenterol. 2016 Jul;50(6):464–9.
12.
Loperfido S, Baldo V, Piovesana E, Bellina L, Rossi K, Groppo M, et al. Changing trends in acute upper-GI bleeding: a population-based study. Gastrointest Endosc. 2009 Aug;70(2):212–24.
13.
Nahon S, Pariente A, Nalet B, Hagege H, Latrive JP.; group of investigators of the ANGH (Association Nationale des Gastroentérologues des Hôpitaux Généraux). Causes of mortality related to peptic ulcer bleeding in a prospective cohort of 965 French patients: a plea for primary prevention. Am J Gastroenterol. 2010 Aug;105(8):1902–3.
14.
Jiménez-Rosales R, Valverde-López F, Vadillo-Calles F, Martínez-Cara JG, López de Hierro M, Redondo-Cerezo E. Inhospital and delayed mortality after upper gastrointestinal bleeding: an analysis of risk factors in a prospective series. Scand J Gastroenterol. 2018 Jun;53(6):714–20.
15.
Strate LL, Orav EJ, Syngal S. Early predictors of severity in acute lower intestinal tract bleeding. Arch Intern Med. 2003 Apr;163(7):838–43.
16.
Matsumoto T, Inokuma T. Clinical course and rebleeding predictors of acute haemorrhagic rectal ulcer: 5-year experience and review of the literature. Colorectal Dis. 2013 Jul;15(7):878–84.
17.
Nishimura N, Mizuno M, Shimodate Y, Doi A, Mouri H, Matsueda K. Risk factors for recurrent bleeding from acute hemorrhagic rectal ulcer. Scand J Gastroenterol. 2018 Jun - Jul;53(7):831–4.
18.
Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982 Dec;5(6):649–55.
19.
Nahon S, Nouel O, Hagège H, Cassan P, Pariente A, Combes R, et al.; Groupe des Hémorragies Digestives Hautes de l’Association Nationale des Hépatogastroentérologues des hôpitaux Généraux. Favorable prognosis of upper-gastrointestinal bleeding in 1041 older patients: results of a prospective multicenter study. Clin Gastroenterol Hepatol. 2008 Aug;6(8):886–92.
20.
Ur-Rahman A, Guan J, Khalid S, Munaf A, Sharbatji M, Idrisov E, et al. Both Full Glasgow-Blatchford Score and Modified Glasgow-Blatchford Score Predict the Need for Intervention and Mortality in Patients with Acute Lower Gastrointestinal Bleeding. Dig Dis Sci. 2018 Nov;63(11):3020–5.
21.
Lau JY, Sung JJ, Lee KK, Yung MY, Wong SK, Wu JC, et al. Effect of intravenous omeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers. N Engl J Med. 2000 Aug;343(5):310–6.
22.
Sung JJ, Tsoi KK, Lai LH, Wu JC, Lau JY. Endoscopic clipping versus injection and thermo-coagulation in the treatment of non-variceal upper gastrointestinal bleeding: a meta-analysis. Gut. 2007 Oct;56(10):1364–73.
23.
Lanas A, García-Rodríguez LA, Polo-Tomás M, Ponce M, Alonso-Abreu I, Perez-Aisa MA, et al. Time trends and impact of upper and lower gastrointestinal bleeding and perforation in clinical practice. Am J Gastroenterol. 2009 Jul;104(7):1633–41.
24.
Rahme E, Roussy JP, Woolcott J, Nedjar H, Barkun A. Mortality and readmission rates after hospitalization for upper and lower gastrointestinal events in Quebec, Canada. J Clin Gastroenterol. 2013 Aug;47(7):586–92.
25.
Oku T, Maeda M, Ihara H, Umeda I, Kitaoka K, Waga E, et al. Clinical and endoscopic features of acute hemorrhagic rectal ulcer. J Gastroenterol. 2006 Oct;41(10):962–70.
26.
Asayama N, Oka S, Tanaka S. Polyglycolic acid sheet application for intractable acute hemorrhagic rectal ulcer. Dig Endosc. 2016 Sep;28(6):689.
27.
Lin CK, Liang CC, Chang HT, Hung FM, Lee TH. Acute hemorrhagic rectal ulcer: an important cause of lower gastrointestinal bleeding in the critically ill patients. Dig Dis Sci. 2011 Dec;56(12):3631–7.
28.
Nagata N, Ishii N, Manabe N, Tomizawa K, Urita Y, Funabiki T, et al. Guidelines for Colonic Diverticular Bleeding and Colonic Diverticulitis: Japan Gastroenterological Association. Digestion. 2019;99 Suppl 1:1–26.
29.
Camus M, Jensen DM, Ohning GV, Kovacs TO, Jutabha R, Ghassemi KA, et al. Comparison of Three Risk Scores to Predict Outcomes of Severe Lower Gastrointestinal Bleeding. J Clin Gastroenterol. 2016 Jan;50(1):52–8.
30.
Ando M, Ando Y, Hasegawa Y, Shimokata K, Minami H, Wakai K, et al. Prognostic value of performance status assessed by patients themselves, nurses, and oncologists in advanced non-small cell lung cancer. Br J Cancer. 2001 Nov;85(11):1634–9.
© 2019 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2019
You do not currently have access to this content.